NIAID Makes Moves to Secure Patent Interests in COVID-19 Vaccine Patents

NIAID Makes Moves to Secure Patent Interests in COVID-19 Vaccine Patents

On November 15, NIH reported that it has been engaging with Moderna in “good faith discussions” to settle months of disputes regarding the firm’s patent applications, as reported that day by Yahoo. Moderna has offered to share the patents on its COVID-19 vaccine with the US government, along with allowing the government to “license the patents as they see fit.” Moderna asserts that the “strict rules” of US patent law required it to list only its own researchers, “as the inventors on these claims.” Yet NIAID objects, noting that, “its own thorough review” found that their scientists Kizzmekia Corbett, Barney Graham, and John Mascola should also be listed as inventors. "Moderna has made a serious mistake here in not providing the kind of co-inventorship credit to people who played a major role in the development of the vaccine that they are now making a fair amount of money off of," NIH’s director Dr. Francis Collins told Reuters. "Omitting NIH inventors from the principal patent application deprives NIH of a co-ownership interest in that application and the patent that will eventually issue from it," offered an NIAID spokesperson.  TrialSite notes that Moderna has benefited from in...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

Personal
$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
Professional
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee